Difference between revisions of "S100A11 (TG2)"
m |
m |
||
| Line 53: | Line 53: | ||
that acquires the capacity to signal through the p38 MAPK pathway, accelerate | that acquires the capacity to signal through the p38 MAPK pathway, accelerate | ||
| − | chondrocyte hypertrophy and matrix catabolism | + | chondrocyte hypertrophy and matrix catabolism. |
|- | |- | ||
|Video | |Video | ||
Revision as of 09:38, 11 June 2008
| Template:Infobox header| S100A11 (TG2) | |
|---|---|
| |
| Substrate peptide name | S100A11 |
| Synonyms | S100 calcium-binding protein A11
Calgizzarin |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol
Keratinocyte cornified envelope |
| Swissprot ID | P31949 |
| Reactive glutamines | Q102 |
| Reactive lysines | K3 |
| Substrate sequence | KAVPSQKRT
MASKISSPT |
| Structure | 1QLS |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:9446578 |
| Notes | Transamidation by TG2 transforms S100A11 into a covalently bonded homodimer
that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism. |
| Video | 1qxapT72gvd7lkY0F|300}} |
| Template:Infobox header | | |
